Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOryx International Growth Regulatory News (OIG)

Share Price Information for Oryx International Growth (OIG)

Share Price is delayed by 15 minutes
Get Live Data
1,280.00    5.00 (0.39%)
Bid:
1,230.00
Ask:
1,305.00
Spread: 75.00 (6.098%)
Market Cap: £179.20m
OIG Live PriceLast checked at - London Stock Exchange

Intraday Oryx International Growth Share Chart

Interim Management Statement

8 Aug 2011 11:45

RNS Number : 9283L
Oryx International Growth Fund Ld
08 August 2011
 

ORYX INTERNATIONAL GROWTH FUND LIMITED

 8 August 2011

 INTERIM MANAGEMENT STATEMENT FOR THE QUARTER ENDED 30 JUNE 2011

Oryx International Growth Fund Limited ("Oryx" or the "Company"), is publishing this Interim Management Statement in accordance with DTR 4.3 of the FSA Handbook.

This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

This interim management statement relates to the period from 1 April 2011 to 30 June 2011, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 Manager's Review

Markets drifted for the majority of the period under review with the FTSE Small Cap TR Index up 0.7% and the FTSE All-Share TR Index (£) down 0.9%. It is pleasing to report that against this backdrop the net asset value rose by 8.8% to 296p per share. The increase in the portfolio was broadly based, although there was no movement in the value of the unquoted portfolio. Whilst current market conditions are difficult the manager believes there is inherent value in the portfolio which will be realised in the next quarter.

Material TransactionsSince 1 April 2011 the Company has purchased for cancellation the following shares:

15 April 2011 a total of 250,000 ordinary shares at a gross price of £2.30 per share.27 May 2011 a total of 170,000 ordinary shares at a gross price of £2.30 per share.

Material EventsThere were no material events during the quarter ended 30 June 2011.

Report and AccountsOn 30 June 2011, the Company posted its Annual Report for the year ended 31 March 2011 to Shareholders together with a circular containing the Notice convening the Company's AGM at 11am on 12 August 2011 and details of a proposed waiver of the Rule 9 provisions of the City Code on Takeovers and Mergers.

 

Financial Highlights

 

 

30 June 2011

31 March 2011

31 December 2010

30 June 2010

 

 

 

 

 

NAV

£2.96

£2.72

£2.81

£2.35

 

 

 

 

 

US Dollar / Sterling Exchange Rate

 1.6055

 1.6029

 1.5657

 1.4961

 

 

 

 

 

 

 

Twenty Largest Equity Investments at 30 June 2011

 

% Net Assets

RPC Group Plc

7.60

CVS Group Plc

7.01

Guinness Peat Group Plc

6.72

BBA Aviation Plc

6.38

Gleeson (M.J.) Group Plc

6.11

Augean

5.34

Orthoproducts Ltd

4.68

Quarto Group Inc

4.54

GTL Resources Plc

4.19

Bavaria Industriekapital AG

4.02

Idox Plc

3.92

Sinclair Pharma Plc

3.51

Innovation Group Plc

3.39

Catalyst Media Group Plc

3.38

Redhall Group Plc

3.21

Journey Group Plc

2.99

Nastor Inv Ltd Zero Redeem Prefer Shares

2.38

Bionostics Holdings Ltd

2.19

Green Co2 Plc

2.13

Celsis AG

1.64

85.33

 

The financial information for the quarter ended 30 June 2011 contained within this Interim Management Statement has not been audited.

By order of the Board

BNP Paribas Fund Services (Guernsey) Limited, for and on behalf ofOryx International Growth Fund Limitedas Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUGUUPRUPGGUR
Date   Source Headline
9th Jan 20259:40 amRNSNet Asset Value(s)
9th Dec 202411:08 amRNSNet Asset Value(s)
6th Dec 20244:16 pmRNSHalf-year Report
11th Nov 20241:09 pmRNSNet Asset Value(s)
4th Nov 202412:50 pmRNSDirector/PDMR Shareholding
30th Oct 202410:52 amRNSOffer to acquire GYG Plc
30th Oct 20248:37 amRNSBid for Eckoh plc
8th Oct 20241:16 pmRNSNet Asset Value(s)
17th Sep 202412:10 pmRNSDirector/PDMR Shareholding
13th Sep 20243:19 pmRNSDirector/PDMR Shareholding
13th Sep 20243:16 pmRNSDirector/PDMR Shareholding
13th Sep 20249:42 amRNSDirector/PDMR Shareholding
12th Sep 20243:50 pmRNSDirector/PDMR Shareholding
12th Sep 20243:49 pmRNSDirector/PDMR Shareholding
9th Sep 202412:19 pmRNSNet Asset Value(s)
6th Sep 20242:01 pmRNSDirector/PDMR Shareholding
3rd Sep 20242:46 pmRNSDirector/PDMR Shareholding
2nd Sep 20244:27 pmRNSDirector/PDMR Shareholding
22nd Aug 202410:50 amRNSResult of AGM
9th Aug 20242:31 pmRNSDirector/PDMR Shareholding
8th Aug 202411:24 amRNSNet Asset Value(s)
1st Aug 20247:00 amRNSDirectorate Change
26th Jul 20244:00 pmRNSNotice of AGM
11th Jul 202410:24 amRNSNet Asset Value(s)
10th Jul 20247:00 amRNSInvestor Presentation
4th Jul 20247:00 amRNSAnnual Financial Report
11th Jun 202410:41 amRNSNet Asset Value(s)
10th May 20249:26 amRNSNet Asset Value(s)
10th Apr 20244:34 pmRNSNet Asset Value(s)
15th Mar 202410:01 amRNSHolding(s) in Company
8th Mar 20245:18 pmRNSNet Asset Value(s)
1st Mar 20249:48 amRNSDirector/PDMR Shareholding
26th Feb 202410:54 amRNSDirector/PDMR Shareholding
19th Feb 202411:51 amRNSDirector/PDMR Shareholding
13th Feb 20245:10 pmRNSDirector/PDMR Shareholding
7th Feb 202410:50 amRNSNet Asset Value(s)
18th Jan 20243:19 pmRNSDirector/PDMR Shareholding
15th Jan 20244:35 pmRNSHolding(s) in Company
9th Jan 20244:17 pmRNSNet Asset Value(s)
5th Jan 20249:21 amRNSDirector/PDMR Shareholding
15th Dec 202310:30 amRNSDirector Declaration
11th Dec 202312:52 pmRNSNet Asset Value(s)
21st Nov 202310:21 amRNSHalf-year Report
16th Nov 20238:59 amRNSProposed Sale of The City Pub Group plc
9th Nov 202310:20 amRNSNet Asset Value(s)
19th Oct 20239:00 amRNSInvestment Update
9th Oct 20232:40 pmRNSNet Asset Value(s)
6th Oct 202312:09 pmRNSUpdate on proposed bids for holdings
7th Sep 20235:02 pmRNSNet Asset Value(s)
24th Aug 202310:50 amRNSResult of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.